Table 3.
Healthy participants |
Patients |
|||
---|---|---|---|---|
Mean (μm) (95% limits of agreement) | R2 | Mean (μm) (95% limits of agreement) | R2 | |
TEMP RNFL | −6.3 (3.4 to 0.14×Temp RNFL thickness ± 18.0) | 0.76* | −7.8 (3.3 to 0.18×Temp RNFL thickness ± 10.0) | 0.85* |
SUP RNFL | −9.6 (3.4 to 0.11×Sup RNFL thickness ± 24.9) | 0.47* | −8.7 (14.6 to 0.24×Sup RNFL thickness ± 18.4) | 0.75* |
NAS RNFL | −7 (20.1 to 0.36×Nas RNFL thickness ± 20.0) | 0.55* | −1.5 (34 to 0.52×Nas RNFL thickness ± 17.4) | 0.54* |
INF RNFL | −9 (9.2 to 0.15×Inf RNFL thickness ± 20.4) | 0.69* | −4.5 (4.5 to 0.09×Inf RNFL thickness ± 14.5) | 0.86* |
AVG RNFL | −8 (11.0 to 0.19×Avg RNFL thickness ± 7.0) | 0.87* | −5.7 (12.4 to 0.23×Avg RNFL thickness ± 7.9) | 0.92* |
95% limits of agreement are expresses as bo+ b1×value of retinal nerve fibre layer (RNFL) thickness ±1.96SDresiduals.
AVG RNFL, average RNFL thickness; INF RNFL, inferior quadrant RNFL thickness; NAS RNFL, nasal quadrant RNFL thickness; RNFL, retinal nerve fibre layer; SUP RNFL, superior quadrant RNFL thickness; TEMP RNFL, temporal quadrant RNFL thickness.